NEW YORK – A clinical research study recently launched by researchers at Weill Cornell Medicine, New York Presbyterian, and the New York Genome Center, with support from Illumina, aims to determine the diagnostic value of clinical whole-genome sequencing in a variety of disease types.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.